Sanvas Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Nagpur, Maharashtra, India, established in 2019.
2019 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Sanvas Pharma Private Limited

Sanvas Pharma Private Limited, a active private limited company, was established on 08 February 2019 in Nagpur, Maharashtra, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U51100MH2019PTC320827. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Santosh Pundlikrao Khobragade (Director), Saurabh Santosh Khobragade (Director). Past directors included Mayur Bhimrao Kale, Prabhat Jain. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No.2708/A/17 Gadge Baba Nagar, Nagpur, Maharashtra, 440009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51100MH2019PTC320827

  • Registration Number

    320827

  • Incorporation Date

    08 February 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 1 Day
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 179.20%
  • Ebitda **** -5214.00%
  • Net Worth 8.80%
  • Total Assets **** 290.17%
Company report

Sanvas Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sanvas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sanvas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Santosh Pundlikrao Khobragade Director 15 Feb 2020 Current
Saurabh Santosh Khobragade Director 08 Feb 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jan 2020 Past
Pramod Abcsdd Director 22 Jan 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanvas Pharma.

Sanvas Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 179.2% increase in profit. The company's net worth moved up by a moderate rise of 8.8%.

Sanvas Pharma revenue growth over time
Sanvas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 290.17%
*******
*******
*******
*******
Profit or Loss
*******
 179.20%
*******
*******
*******
*******
Net Worth
*******
 8.80%
*******
*******
*******
*******
EBITDA
*******
 -5214.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanvas Pharma?

Unlock access to Sanvas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sanvas Pharma?

Unlock and access historical data on people associated with Sanvas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanvas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanvas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanvas Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Sanvas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sanvas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Santosh Pundlikrao Khobragade was appointed as a Director was appointed as a Director on 15 Feb 2020 & has been associated with this company since 5 years 11 months . was documented.

  • Director Appointment

    The activity Saurabh Santosh Khobragade was appointed as a Director was appointed as a Director on 08 Feb 2019 & has been associated with this company since 7 years 1 day . was completed.

  • Company Incorporation

    The activity Sanvas Pharma Private Limited was registered on 08 Feb 2019 with Roc Mumbai & aged 7 years 1 day as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sanvas Pharma Private Limited?

The CIN of Sanvas Pharma Private Limited is U51100MH2019PTC320827.

Where is Sanvas Pharma Private Limited headquartered?

Sanvas Pharma Private Limited is headquartered at H.No.2708/A/17 Gadge Baba Nagar, Nagpur, Maharashtra, 440009.

When was Sanvas Pharma Private Limited incorporated?

Sanvas Pharma Private Limited was incorporated on 08 February 2019.

Who are the current directors of Sanvas Pharma Private Limited?

The current directors of Sanvas Pharma Private Limited are

What is the primary industry of Sanvas Pharma Private Limited?

The primary industry of Sanvas Pharma Private Limited is Healthcare.

Is Sanvas Pharma Private Limited a listed company?

Sanvas Pharma Private Limited is unlisted.

What is the capital structure of Sanvas Pharma Private Limited?

The authorized capital of Sanvas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sanvas Pharma Private Limited?

The compliance status of Sanvas Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available